Semin Respir Crit Care Med 2014; 35(01): 099-111
DOI: 10.1055/s-0033-1363456
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Noninvasive Imaging of Pulmonary Hypertension

Karl-Friedrich Kreitner
1   Department of Diagnostic and Interventional Radiology, Universitätsmedizin, Johannes Gutenberg-University, Mainz, Germany
› Author Affiliations
Further Information

Publication History

Publication Date:
30 January 2014 (online)

Abstract

Pulmonary hypertension is defined as a resting mean pulmonary arterial pressure of 25 mm Hg or more determined at right heart catheterization. The challenges for imaging in patients with suspected PH are fivefold: the imaging modality should have a high diagnostic accuracy with regard to the presence of PH; it should be able to characterize the underlying disease, and allow for quantification of its extent by measuring pulmonary hemodynamics. Finally, it should provide prognostic information, and can be used for monitoring of therapy. There have been tremendous improvements in assessment of PH by computed tomography (CT) and magnetic resonance (MR) technology in recent years. This overview tries to elucidate the potential role of each imaging modality and summarizes the most important results that have been achieved so far. In general, after implementation of multidetector technology, CT is superior to MR in assessment of parenchymal and vascular pathologies of the lung, and with electrocardiogram-triggered data acquisition allows for assessment of cardiac structures. The implementation of iodine maps as surrogate for lung perfusion will enable functional assessment of lung perfusion by CT. MR imaging is the reference standard for assessment of cardiac structure and function and allows for physiologic assessment of the pulmonary vasculature. New developments show that with MR techniques, an estimation of hemodynamic parameters such as mean pulmonary arterial pressure and pulmonary vascular resistance will be possible. Actually, CT and MR imaging should be considered as complementary investigations providing comprehensive information in patients with pulmonary hypertension.

 
  • References

  • 1 Apostolakis S, Konstantinides S. The right ventricle in health and disease: insights into physiology, pathophysiology and diagnostic management. Cardiology 2012; 121 (4) 263-273
  • 2 Stevens GR, Fida N, Sanz J. Computed tomography and cardiac magnetic resonance imaging in pulmonary hypertension. Prog Cardiovasc Dis 2012; 55 (2) 161-171
  • 3 Peña E, Dennie C, Veinot J, Muñiz SH. Pulmonary hypertension: how the radiologist can help. Radiographics 2012; 32 (1) 9-32
  • 4 D'Alonzo GE, Barst RJ, Ayres SM , et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med 1991; 115 (5) 343-349
  • 5 Simonneau G, Robbins IM, Beghetti M , et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2009; 54 (1, Suppl): S43-S54
  • 6 Badesch DB, Raskob GE, Elliott CG , et al. Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry. Chest 2010; 137 (2) 376-387
  • 7 Humbert M, Sitbon O, Chaouat A , et al. Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med 2006; 173 (9) 1023-1030
  • 8 Peacock AJ, Murphy NF, McMurray JJ, Caballero L, Stewart S. An epidemiological study of pulmonary arterial hypertension. Eur Respir J 2007; 30 (1) 104-109
  • 9 Schiebler ML, Bhalla S, Runo J , et al. Magnetic resonance and computed tomography imaging of the structural and functional changes of pulmonary arterial hypertension. J Thorac Imaging 2013; 28 (3) 178-193
  • 10 Strange G, Playford D, Stewart S , et al. Pulmonary hypertension: prevalence and mortality in the Armadale echocardiography cohort. Heart 2012; 98 (24) 1805-1811
  • 11 Brown K, Gutierrez AJ, Mohammed T-LH , et al; Expert Panel on Thoracic Imaging. ACR Appropriateness Criteria® pulmonary hypertension. J Thorac Imaging 2013; 28 (4) W57–W60
  • 12 Galiè N, Hoeper MM, Humbert M , et al; ESC Committee for Practice Guidelines (CPG). Guidelines for the diagnosis and treatment of pulmonary hypertension. The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 2009; 30 (20) 2493-2537
  • 13 McLaughlin VV, Archer SL, Badesch DB , et al; ACCF/AHA. ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association. Circulation 2009; 119 (16) 2250-2294
  • 14 Tsai I-C, Tsai W-L, Wang K-Y , et al. Comprehensive MDCT evaluation of patients with pulmonary hypertension: diagnosing underlying causes with the updated Dana Point 2008 classification. AJR Am J Roentgenol 2011; 197 (3) W471–W481
  • 15 Ley S, Kreitner K-F, Fink C, Heussel C-P, Borst MM, Kauczor H-U. Assessment of pulmonary hypertension by CT and MR imaging. Eur Radiol 2004; 14 (3) 359-368
  • 16 Nagendran J, Michelakis E. MRI: one-stop shop for the comprehensive assessment of pulmonary arterial hypertension?. Chest 2007; 132 (1) 2-5
  • 17 Sallach SM, Peshock RM, Reimold S. Noninvasive cardiac imaging in pulmonary hypertension. Cardiol Rev 2007; 15 (2) 97-101
  • 18 Devaraj A, Hansell DM. Computed tomography signs of pulmonary hypertension: old and new observations. Clin Radiol 2009; 64 (8) 751-760
  • 19 Chan AL, Juarez MM, Shelton DK , et al. Novel computed tomographic chest metrics to detect pulmonary hypertension. BMC Med Imaging 2011; 11: 7
  • 20 Mahammedi A, Oshmyansky A, Hassoun PM, Thiemann DR, Siegelman SS. Pulmonary artery measurements in pulmonary hypertension: the role of computed tomography. J Thorac Imaging 2013; 28 (2) 96-103
  • 21 Devaraj A, Wells AU, Meister MG, Corte TJ, Wort SJ, Hansell DM. Detection of pulmonary hypertension with multidetector CT and echocardiography alone and in combination. Radiology 2010; 254 (2) 609-616
  • 22 Zisman DA, Karlamangla AS, Ross DJ , et al. High-resolution chest CT findings do not predict the presence of pulmonary hypertension in advanced idiopathic pulmonary fibrosis. Chest 2007; 132 (3) 773-779
  • 23 Devaraj A, Wells AU, Meister MG, Corte TJ, Hansell DM. The effect of diffuse pulmonary fibrosis on the reliability of CT signs of pulmonary hypertension. Radiology 2008; 249 (3) 1042-1049
  • 24 Rajaram S, Swift AJ, Capener D , et al. Comparison of the diagnostic utility of cardiac magnetic resonance imaging, computed tomography, and echocardiography in assessment of suspected pulmonary arterial hypertension in patients with connective tissue disease. J Rheumatol 2012; 39 (6) 1265-1274
  • 25 Revel M-P, Faivre J-B, Remy-Jardin M, Delannoy-Deken V, Duhamel A, Remy J. Pulmonary hypertension: ECG-gated 64-section CT angiographic evaluation of new functional parameters as diagnostic criteria. Radiology 2009; 250 (2) 558-566
  • 26 Groves AM, Win T, Charman SC, Wisbey C, Pepke-Zaba J, Coulden RA. Semi-quantitative assessment of tricuspid regurgitation on contrast-enhanced multidetector CT. Clin Radiol 2004; 59 (8) 715-719
  • 27 Aviram G, Cohen D, Steinvil A , et al. Significance of reflux of contrast medium into the inferior vena cava on computerized tomographic pulmonary angiogram. Am J Cardiol 2012; 109 (3) 432-437
  • 28 Saba TS, Foster J, Cockburn M, Cowan M, Peacock AJ. Ventricular mass index using magnetic resonance imaging accurately estimates pulmonary artery pressure. Eur Respir J 2002; 20 (6) 1519-1524
  • 29 Swift AJ, Rajaram S, Condliffe R , et al. Diagnostic accuracy of cardiovascular magnetic resonance imaging of right ventricular morphology and function in the assessment of suspected pulmonary hypertension results from the ASPIRE registry. J Cardiovasc Magn Reson 2012; 14: 40
  • 30 Alunni JP, Degano B, Arnaud C , et al. Cardiac MRI in pulmonary artery hypertension: correlations between morphological and functional parameters and invasive measurements. Eur Radiol 2010; 20 (5) 1149-1159
  • 31 Roeleveld RJ, Marcus JT, Faes TJ , et al. Interventricular septal configuration at MR imaging and pulmonary arterial pressure in pulmonary hypertension. Radiology 2005; 234 (3) 710-717
  • 32 Dellegrottaglie S, Sanz J, Poon M , et al. Pulmonary hypertension: accuracy of detection with left ventricular septal-to-free wall curvature ratio measured at cardiac MR. Radiology 2007; 243 (1) 63-69
  • 33 Sanz J, Dellegrottaglie S, Kariisa M , et al. Prevalence and correlates of septal delayed contrast enhancement in patients with pulmonary hypertension. Am J Cardiol 2007; 100 (4) 731-735
  • 34 Blyth KG, Groenning BA, Martin TN , et al. Contrast enhanced-cardiovascular magnetic resonance imaging in patients with pulmonary hypertension. Eur Heart J 2005; 26 (19) 1993-1999
  • 35 Shehata ML, Lossnitzer D, Skrok J , et al. Myocardial delayed enhancement in pulmonary hypertension: pulmonary hemodynamics, right ventricular function, and remodeling. AJR Am J Roentgenol 2011; 196 (1) 87-94
  • 36 Ley S, Grünig E, Kiely DG, van Beek E, Wild J. Computed tomography and magnetic resonance imaging of pulmonary hypertension: Pulmonary vessels and right ventricle. J Magn Reson Imaging 2010; 32 (6) 1313-1324
  • 37 Grosse C, Grosse A. CT findings in diseases associated with pulmonary hypertension: a current review. Radiographics 2010; 30 (7) 1753-1777
  • 38 Failo R, Wielopolski PA, Tiddens HA, Hop WC, Mucelli RP, Lequin MH. Lung morphology assessment using MRI: a robust ultra-short TR/TE 2D steady state free precession sequence used in cystic fibrosis patients. Magn Reson Med 2009; 61 (2) 299-306
  • 39 Ley-Zaporozhan J, Ley S, Kauczor HU. Proton MRI in COPD. COPD 2007; 4 (1) 55-65
  • 40 Ley-Zaporozhan J, Ley S, Eberhardt R, Kauczor HU, Heussel CP. Visualization of morphological parenchymal changes in emphysema: comparison of different MRI sequences to 3D-HRCT. Eur J Radiol 2010; 73 (1) 43-49
  • 41 Rajaram S, Swift AJ, Capener D , et al. Lung morphology assessment with balanced steady-state free precession MR imaging compared with CT. Radiology 2012; 263 (2) 569-577
  • 42 Castañer E, Gallardo X, Ballesteros E , et al. CT diagnosis of chronic pulmonary thromboembolism. Radiographics 2009; 29 (1) 31-50 , discussion 50–53
  • 43 Kreitner KF, Ley S, Kauczor HU , et al. Chronic thromboembolic pulmonary hypertension: pre- and postoperative assessment with breath-hold MR imaging techniques. Radiology 2004; 232 (2) 535-543
  • 44 Kreitner KF, Kunz RP, Ley S , et al. Chronic thromboembolic pulmonary hypertension - assessment by magnetic resonance imaging. Eur Radiol 2007; 17 (1) 11-21
  • 45 Piazza G, Goldhaber SZ. Chronic thromboembolic pulmonary hypertension. N Engl J Med 2011; 364 (4) 351-360
  • 46 Mayer E, Jenkins D, Lindner J , et al. Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: results from an international prospective registry. J Thorac Cardiovasc Surg 2011; 141 (3) 702-710
  • 47 Ley S, Ley-Zaporozhan J, Pitton MB , et al. Diagnostic performance of state-of-the-art imaging techniques for morphological assessment of vascular abnormalities in patients with chronic thromboembolic pulmonary hypertension (CTEPH). Eur Radiol 2012; 22 (3) 607-616
  • 48 Rajaram S, Swift AJ, Capener D , et al. Diagnostic accuracy of contrast-enhanced MR angiography and unenhanced proton MR imaging compared with CT pulmonary angiography in chronic thromboembolic pulmonary hypertension. Eur Radiol 2012; 22 (2) 310-317
  • 49 Ley S, Kreitner KF, Morgenstern I, Thelen M, Kauczor HU. Bronchopulmonary shunts in patients with chronic thromboembolic pulmonary hypertension: evaluation with helical CT and MR imaging. AJR Am J Roentgenol 2002; 179 (5) 1209-1215
  • 50 Remy-Jardin M, Duhamel A, Deken V, Bouaziz N, Dumont P, Remy J. Systemic collateral supply in patients with chronic thromboembolic and primary pulmonary hypertension: assessment with multi-detector row helical CT angiography. Radiology 2005; 235 (1) 274-281
  • 51 Ley S, Fink C, Zaporozhan J , et al. Value of high spatial and high temporal resolution magnetic resonance angiography for differentiation between idiopathic and thromboembolic pulmonary hypertension: initial results. Eur Radiol 2005; 15 (11) 2256-2263
  • 52 Ohno Y, Hatabu H, Murase K , et al. Primary pulmonary hypertension: 3D dynamic perfusion MRI for quantitative analysis of regional pulmonary perfusion. AJR Am J Roentgenol 2007; 188 (1) 48-56
  • 53 Rajaram S, Swift AJ, Telfer A , et al. 3D contrast-enhanced lung perfusion MRI is an effective screening tool for chronic thromboembolic pulmonary hypertension: results from the ASPIRE Registry. Thorax 2013; 68 (7) 677-678
  • 54 Hoey ETD, Mirsadraee S, Pepke-Zaba J, Jenkins DP, Gopalan D, Screaton NJ. Dual-energy CT angiography for assessment of regional pulmonary perfusion in patients with chronic thromboembolic pulmonary hypertension: initial experience. AJR Am J Roentgenol 2011; 196 (3) 524-532
  • 55 Renard B, Remy-Jardin M, Santangelo T , et al. Dual-energy CT angiography of chronic thromboembolic disease: can it help recognize links between the severity of pulmonary arterial obstruction and perfusion defects?. Eur J Radiol 2011; 79 (3) 467-472
  • 56 Roeleveld RJ, Marcus JT, Boonstra A , et al. A comparison of noninvasive MRI-based methods of estimating pulmonary artery pressure in pulmonary hypertension. J Magn Reson Imaging 2005; 22 (1) 67-72
  • 57 Sanz J, Kuschnir P, Rius T , et al. Pulmonary arterial hypertension: noninvasive detection with phase-contrast MR imaging. Radiology 2007; 243 (1) 70-79
  • 58 Hagger D, Condliffe R, Woodhouse N , et al. Ventricular mass index correlates with pulmonary artery pressure and predicts survival in suspected systemic sclerosis-associated pulmonary arterial hypertension. Rheumatology (Oxford) 2009; 48 (9) 1137-1142
  • 59 Sanz J, Kariisa M, Dellegrottaglie S , et al. Evaluation of pulmonary artery stiffness in pulmonary hypertension with cardiac magnetic resonance. JACC Cardiovasc Imaging 2009; 2 (3) 286-295
  • 60 Nogami M, Ohno Y, Koyama H , et al. Utility of phase contrast MR imaging for assessment of pulmonary flow and pressure estimation in patients with pulmonary hypertension: comparison with right heart catheterization and echocardiography. J Magn Reson Imaging 2009; 30 (5) 973-980
  • 61 García-Alvarez A, Fernández-Friera L, Mirelis JG , et al. Non-invasive estimation of pulmonary vascular resistance with cardiac magnetic resonance. Eur Heart J 2011; 32 (19) 2438-2445
  • 62 Swift AJ, Rajaram S, Hurdman J , et al. Noninvasive estimation of PA pressure, flow, and resistance with CMR imaging: derivation and prospective validation study from the ASPIRE Registry. JACC Cardiovasc Imaging 2013; 6 (10) 1036-1047
  • 63 Abolmaali N, Seitz U, Esmaeili A , et al. Evaluation of a resistance-based model for the quantification of pulmonary arterial hypertension using MR flow measurements. J Magn Reson Imaging 2007; 26 (3) 646-653
  • 64 Kreitner KF, Wirth GM, Krummenauer F , et al. Non-invasive assessment of pulmonary hemodynamics in patients with chronic thromboembolic pulmonary hypertension (CTEPH) by high temporal resolution phase-contrast MR imaging: correlation with simultaneous invasive pressure recordings. Circ Cardiovasc Imaging 2013; 6 (5) 722-729
  • 65 van Wolferen SA, Marcus JT, Boonstra A , et al. Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension. Eur Heart J 2007; 28 (10) 1250-1257
  • 66 Swift AJ, Rajaram S, Condliffe R , et al. Pulmonary artery relative area change detects mild elevations in pulmonary vascular resistance and predicts adverse outcome in pulmonary hypertension. Invest Radiol 2012; 47 (10) 571-577
  • 67 Freed BH, Gomberg-Maitland M, Chandra S , et al. Late gadolinium enhancement cardiovascular magnetic resonance predicts clinical worsening in patients with pulmonary hypertension. J Cardiovasc Magn Reson 2012; 14: 11
  • 68 Reesink HJ, Marcus JT, Tulevski II , et al. Reverse right ventricular remodeling after pulmonary endarterectomy in patients with chronic thromboembolic pulmonary hypertension: utility of magnetic resonance imaging to demonstrate restoration of the right ventricle. J Thorac Cardiovasc Surg 2007; 133 (1) 58-64
  • 69 Iino M, Dymarkowski S, Chaothawee L, Delcroix M, Bogaert J. Time course of reversed cardiac remodeling after pulmonary endarterectomy in patients with chronic pulmonary thromboembolism. Eur Radiol 2008; 18 (4) 792-799
  • 70 Mauritz GJ, Vonk-Noordegraaf A, Kind T , et al. Pulmonary endarterectomy normalizes interventricular dyssynchrony and right ventricular systolic wall stress. J Cardiovasc Magn Reson 2012; 14: 5
  • 71 Fernandez-Friera L, Garcia-Alvarez A, Guzman G , et al. Apical right ventricular dysfunction in patients with pulmonary hypertension demonstrated with magnetic resonance. Heart 2011; 97 (15) 1250-1256
  • 72 Sanz J, García-Alvarez A, Fernández-Friera L , et al. Right ventriculo-arterial coupling in pulmonary hypertension: a magnetic resonance study. Heart 2012; 98 (3) 238-243
  • 73 Stevens GR, Garcia-Alvarez A, Sahni S, Garcia MJ, Fuster V, Sanz J. RV dysfunction in pulmonary hypertension is independently related to pulmonary artery stiffness. JACC Cardiovasc Imaging 2012; 5 (4) 378-387
  • 74 Shehata ML, Harouni AA, Skrok J , et al. Regional and global biventricular function in pulmonary arterial hypertension: a cardiac MR imaging study. Radiology 2013; 266 (1) 114-122